AIM ImmunoTech Inc.
General ticker "AIM" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $628.2M (TTM average)
AIM ImmunoTech Inc. does not follow the US Stock Market performance with the rate: -15.1%.
Estimated limits based on current volatility of 5.3%: low 1.38$, high 1.53$
Factors to consider:
- Total employees count: 26 as of 2023
- Top business risk factors: Regulatory and compliance, Pandemic risks, Product liability, Economic downturns and volatility, IT system failures
- Current price 81.7% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [8.01$, 30.99$]
- 2025-12-31 to 2026-12-31 estimated range: [3.58$, 14.95$]
Financial Metrics affecting the AIM estimates:
- Negative: with PPE of -0.6 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -1.34 <= 0.33
- Negative: Shareholder equity ratio, % of -15.36 <= 18.93
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
- Negative: 0.01 < Interest expense per share per price, % of 0.05
- Negative: negative Industry operating income (median)
- Negative: -0.15 < Industry inventory ratio change (median), % of 0
Short-term AIM quotes
Long-term AIM plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.14MM | $0.20MM | $0.17MM |
| Operating Expenses | $20.06MM | $32.12MM | $19.94MM |
| Operating Income | $-19.92MM | $-31.92MM | $-19.77MM |
| Non-Operating Income | $0.48MM | $2.95MM | $2.45MM |
| Interest Expense | $0.00MM | $0.00MM | $0.58MM |
| R&D Expense | $6.99MM | $10.93MM | $6.20MM |
| Income(Loss) | $-19.45MM | $-28.96MM | $-17.32MM |
| Profit(Loss)* | $-21.09MM | $-28.96MM | $-17.32MM |
| Stockholders Equity | $38.47MM | $10.23MM | $-1.32MM |
| Inventory | $0.00MM | $0.30MM | $0.00MM |
| Assets | $40.49MM | $19.38MM | $8.61MM |
| Operating Cash Flow | $-16.11MM | $-21.27MM | $-14.89MM |
| Capital expenditure | $0.27MM | $0.58MM | $0.02MM |
| Investing Cash Flow | $10.99MM | $-0.83MM | $4.71MM |
| Financing Cash Flow | $0.08MM | $0.48MM | $6.44MM |
| Earnings Per Share** | $-0.44 | $-0.60 | $-0.31 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.